Cardiovascular (Heart) Disease
The clinical manifestation of congestive heart failure (CHF) has reached an incidence that ranges from 0.1 - 0.5 %1 in developed countries but increases up to 10% in patients 80 years of age or older2. There are many types of cardiovascular disease that can result in CHF with the leading causes being atherosclerosis and hypertension7. We are getting better at diagnosing and treating CHF. However, neither the incidence nor the prognosis of heart failure has changed dramatically over the last two decades5. This indicates that the primary burden of treatment lies in the prevention and maintenance of the different types of cardiovascular diseases that can cause CHF.
For far too many years, the relationship between dietary intake and cardiovascular disease has traditionally focused on the consumption of fat and its impact on blood triglycerides and cholesterol3, 4, 6. However, such an approach is far too simplistic in that it de-emphasizes the ability of dietary nutrients and the interaction of these nutrients to impact gene expression and thus the development and progression of cardiovascular disease on a global scale. Research from my lab and the labs of others have demonstrated that a change in macronutrient intake leads to dramatic differences in gene expression and in some instances the complete reversal (or prevention of cardiovascular disease). The fundamental factor that ties together cardiovascular disease, diet, nutrients and your health is the ability of the heart to make, use, and deliver energy. What is less known is the fact that in the diseased heart, metabolism changes such that the heart becomes less efficient at using and creating energy.
At MHL,we have products specifically formulated for your cardiovascular health. These formulas emphasize proper nutrient intake to optimize the metabolic health of your heart.
MHL Exclusive Heart Combo Packs
At MHL, we believe that nutrients can have a dramatic impact on overall health as a result of targeting those cellular pathways that lead to changes at the genetic level. An effective way to optimize MHL products is to combine formulas in order to target the underlying abnormalities of specific health-related issues.
For this reason, MHL offers combination packs for your specific health needs:
Key Formulas for Cardiovascular Health:
Auralife: AuraLife is a potent, complete multivitimin/mineral complex that is a necessary part of one's nutritional repertoire. A complement of vitamins, minerals, and anti-oxidants to support any wellness program. Auralife should not and cannot replace a nutritionally optimal diet but will provide the necessary component to optimize your wellness. Auralife also includes a proprietary "Balancing Delivery System" for optimal digestion and absorption.
Auralife delivers essential nutrients such as Biotin, a full complement of the B complex including Folic Acid and Choline, antioxidants, vitamins A, C, D, and E including Citrus Biofalvanoids and tocotrienols, minerals such as calcium, magnesium, and phosphorus and trace elements such as chromium, molybdenum, selenium, manganese.
As indicated by a recent finding posted by the American Heart Association inflammation is a critical part of the atherosclerotic process. (http://www.americanheart.org/presenter.jhtml?identifier=4648) Therefore, Auralife is formulated with the anti- inflammatory, Quercitin.
MHL AntiOxidant Formula: The generation of oxygen radicals is a result of normal metabolism and is crucial for certain cellular events. When the production of oxygen radicals becomes excessive, deleterious biological processes begin to accumulate. Your body struggles to keep these oxygen radicals, or reactive oxygen species (ROS), in check. However, especially in today's environment, your body has difficulty suppressing the negative effects of ROS. For example, the harmful effects of cholesterol are due the peroxidation (caused by ROS) of lipids, or fat, carried in the LDL particle not cholesterol as is commonly believed. Therefore, MHL has formulated the "Essential Antioxidation Formula" to help your body keep control ROS in the body. We have provided a convenient 2-month supply of this formula in one bottle.
Moreover, levels of CoQ10 tend to be lower in people with high cholesterol compared to healthy individuals of the same age. In addition, certain cholesterol-lowering drugs called statins (such as atorvastatin, cerivastatin, lovastatin, pravastatin, simvastatin) appear to deplete natural levels of CoQ10 in the body.
Azantis™ Krill Oil: The incorporation of Omega-3 fatty acids is an essential part of cardiovascular health. The American Heart Association states "we recommend that Omega-3 fatty acids benefit the heart of healthy people, and those at high risk of - or who have - cardiovascular disease. We recommend eating fish (particularly fatty fish) at least two times a week. Fish is a good source of protein and doesn't have the high saturated fat that fatty meat products do. Fatty fish like mackerel, lake trout, herring, sardines, albacore tuna and salmon are high in two kinds of omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)". See additional information.
Azantis™ Krill Oil provides a significant amount of Omega-3 fatty acids plus antioxidants: a potent combination for cardiovascular health.
Cholestat: Maintaining healthy cholesterol levels is within everyone's control - it is a matter of making healthy choices. Cholestat can be a one of those healthy choices. Cholestat contains scientifically-proven ingredients which work together synergistically to promote healthy cholesterol levels. The synergy is a result of combining ingredients which support various mechanisms to help control cholesterol build-up such as regulating cholesterol synthesis, preventing cholesterol transportation to the arteries and reducing inflammation which increases plaque build-up. In addition, Cholestat also contains powerful antioxidant compounds which help control oxidation of LDL and therefore reduce plaque formation on the arteries. Regular use of Cholestat can be a first defense in maintaining healthy cholesterol levels and improving your heart health.
- Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, Grobbee DE. The epidemiology of heart failure. Eur Heart J. 1997;18(2):208-225.
- Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22(4 Suppl A):6A-13A.
- Hooper L, Summerbell CD, Higgins JP, Thompson RL, Capps NE, Smith GD, Riemersma RA, Ebrahim S. Dietary fat intake and prevention of cardiovascular disease: systematic review. Bmj. 2001;322(7289):757-763.
- Hooper L, Summerbell CD, Higgins JP, Thompson RL, Clements G, Capps N, Davey S, Riemersma RA, Ebrahim S. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev. 2001(3):CD002137.
- Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM. Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med. 1999;159(1):29-34.
- Tang JL, Armitage JM, Lancaster T, Silagy CA, Fowler GH, Neil HA. Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. Bmj. 1998;316(7139):1213-1220.
- Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Heart J. 1991;121(6 Pt 1):1852-1853.